GRAIL spin-off complete; GRAIL to begin regular way trading as "GRAL" on June 25Illumina to issue second quarter 2024 results…
JERSEY CITY, N.J., June 24, 2024 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report…
Collaboration Establishes AGRF as Premier Provider of Dovetail's Cutting-Edge Genomic Technologies, Boosting Innovation and Access Across Australia and New Zealand…
MARICOPA, Ariz.--(BUSINESS WIRE)--MY DR NOW, a leader in innovative healthcare solutions, is excited to announce the opening of its new…
Novel application supports measurable residual disease (MRD) testing to help monitor cancer and stay ahead of relapse BOSTON and ROLLE, Switzerland,…
SINGAPORE, June 23, 2024 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on…
Jaguar to report pivotal phase 3 OnTarget trial results for its cancer supportive care drug crofelemer on or before July…
LEXINGTON, KY / ACCESSWIRE / June 21, 2024 / NX Development Corp. (NXDC) is pleased to announce a significant milestone.…
100% of patients enrolled achieved a partial response or betterMilder and less frequent drug-related adverse events were observed compared to…